Eloxx Pharmaceuticals, Inc. filed SEC Form 8-K: Entry Into A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Item 3, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Regulation Fd, Other Events, Financial Statements And Exhibits